Category Archives:

By Sangmi Cha SEOUL (Reuters) - South Korea has inoculated 25% of its population with at least one dose of COVID-19 vaccine two weeks ahead of schedule, authorities said on Wednesday, putting the coun...

By Chris Thomas and Sethuraman N R BENGALURU (Reuters) - Like many other twenty-somethings in India, Beverly Coutinho kept postponing buying a life insurance policy, until a surge in COVID-19 cases an...

ATHENS (Reuters) - Public transport staff in Athens went on strike for the second time in a week on Wednesday before a parliamentary vote on a law the government says will revamp outdated labour rules...

TOYOTA CITY (Reuters) - Toyota Motor Corp's shares reached a record high on Wednesday, earning a rare message of thanks from the company's president at its annual general meeting (AGM). The share pric...

By Gopal Sharma KATHMANDU (Reuters) - Flash floods triggered by heavy rains washed away a remote mountain camp in Bhutan on Wednesday killing 10 people and injuring five, while floods in neighbouring ...

(Reuters) - Chickens, cows, paid leave, even a million-dollar apartment, these are the prizes on offer from Thailand to Indonesia to Hong Kong for those who get vaccinated against COVID-19 as nations ...

By Sagarika Jaisinghani (Reuters) -Gains in financial and industrial stocks lifted European shares on Wednesday, though the main equity index held off record highs on nervousness that the U.S. Federal...

By Julie Zhu HONG KONG (Reuters) - China is poised to unveil a much tougher than anticipated crackdown on the country's $120 billion private tutoring industry, four sources told Reuters, including tri...

BEIJING (Reuters) - China said on Wednesday it rejects and deplores a joint statement made by the United States and the European Union that criticised China. The Chinese government firmly opposed any ...

NEW DELHI (Reuters) - India's main opposition party, Congress, on Wednesday questioned the decision by Prime Minister Narendra Modi's government to double the gap between the doses of the AstraZeneca ...